Propionic acidemia (PA) therapeutic: In an ongoing Phase 1/2 study designed to evaluate safety and pharmacology in trial participants with PA, Moderna's investigational therapeutic (mRNA-3927 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback